-
Forward Look
Expanding First-line Therapy OptionsAn antibody-drug conjugate extends progression-free survival for people with advanced triple-negative breast cancer.
by Darcy Lewis
-
When Donor Cells AttackNew strategies are reducing graft-versus-host disease, one of the most dangerous complications of a stem cell transplant.
by Sonya Collins
-
Healthy Habits
Focus on Whole FoodsDiets high in ultraprocessed foods increase the risk for precancerous colorectal polyps in younger women.
by Anne Danahy
-
Q&A
Breaking the Breast Cancer StigmaBreast cancer survivor Judith L. Pearson writes about three women who helped shape modern-day patient advocacy.
by Darlene Dobkowski
-
Survivor Profile
The Ripple EffectProstate cancer survivor Robert Ginyard urges other Black men to share their stories and enroll in clinical trials to increase representation and improve outcomes for future generations.
by Brittany King
-
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
-
Can People With Oral Lesions Avoid Surgery?Injecting immunotherapy directly into precancerous lesions in the mouth can shrink precancerous lesions.
by Eric Fitzsimmons
-
Plant-forward Diet Linked to Lower Risk for Aggressive Breast Cancer SubtypeWomen who ate a diet focused on both human health and sustainability had reduced risk for estrogen receptor-negative disease.
by Thomas Celona
-
CAR T-cell Therapy Prevents Progression in High-risk Smoldering MyelomaEarly study suggests an immunotherapy can eliminate precancerous cells in people with high-risk disease.
by Darlene Dobkowski
-
Aromatase Inhibitor Use Linked to Blood Pressure, Diabetes RiskPeople who took aromatase inhibitors to prevent breast cancer recurrence for at least five years had a higher risk of developing cardiometabolic conditions.
by Eric Fitzsimmons
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
